Patent details

EP2231160 Title: TRYPTAMINE SULFONAMIDES AS 5-HT6 ANTAGONISTS

Basic Information

Publication number:
EP2231160
PCT Application Number:
PCT/US/2008/013104
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP088571229
PCT Publication Number:
WO/2009/073118
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TRYPTAMINE SULFONAMIDES AS 5-HT6 ANTAGONISTS
French Title of Invention:
TRYPTAMINE SULFONAMIDES EN TANT QU'ANTAGONISTES DE 5-HT6
German Title of Invention:
TRYPTAMIN-SULFONAMIDE ALS 5-HT6-ANTAGONISTEN
SPC Number:

Dates

Filing date:
25/11/2008
Grant date:
14/08/2013
EP Publication Date:
14/08/2013
PCT Publication Date:
11/06/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/09/2010
EP B1 Publication Date:
14/08/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/11/2013
Expiration date:
25/11/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/11/2008
 
 

Name:
Merck Sharp & Dohme Corp.
Address:
126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

1

Name:
SZYMONIFKA Michael, J.
Address:
United States (US)

2

Name:
PASTERNAK Alexander
Address:
United States (US)

Priority

Priority Number:
5288
Priority Date:
04/12/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/497;
Filing date Document type Number of pages